Efficacy and Safety of Chinese Medicine Nanbei Decoction Combined With Androgen Blockade in The Treatment of Advanced Prostate Cancer: a Randomized, Double-Blind, Placebo-Controlled Clinical Study
- Conditions
- Advanced Prostate Cancer
- Registration Number
- ITMCTR2000004034
- Lead Sponsor
- Department of Urology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- Not specified
(1) It is in accordance with the diagnostic standard of Western medicine for advanced prostate cancer.
(2) It is in accordance with the TCM diagnostic standard of Qi and yin deficiency syndrome.
(3) In the stage of maximal androgen blockade treatment;
(4) Sign informed consent.
(1) Hepatitis A, hepatitis B, hepatitis C and other infectious diseases;
(2) Abdominal ultrasound showed obstructive disease, abdominal CT showed liver metastasis;
(3) Liver function is not complete;
(4) Severe cardiovascular and cerebrovascular diseases, renal insufficiency and mental history;
(5) Primary malignant tumor, except prostate cancer.
(6) In recent 3 months, he has taken other drugs (including traditional Chinese Medicine) in addition to anti male treatment.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method